Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest diabetes mellitus Stories

2014-02-25 14:23:10

The automatic “threshold suspend” (TS) feature of an insulin pump helps prevent life-threatening hypoglycemic events when the device's sensor detects blood glucose concentrations below the preset threshold. However, in individuals with type 1 diabetes who have had previous episodes of hypoglycemia the TS feature may be less effective at preventing subsequent events, according to important new results from the ASPIRE study published in Diabetes Technology & Therapeutics (DTT), a...

2014-02-25 08:31:50

Once-Weekly Dulaglutide Hits Primary Endpoint in Sixth Consecutive AWARD Trial INDIANAPOLIS, Feb. 25, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive top-line results of the sixth AWARD (Assessment of Weekly AdministRation of LY2189265 in Diabetes) trial for once-weekly dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a treatment for type 2 diabetes. In the AWARD-6 study, once-weekly...

2014-02-24 12:27:34

BERKELY, Calif., Feb. 24, 2014 /PRNewswire/ -- NutritionQuest (http://www.nutritionquest.com), a health and wellness research company in Berkeley, CA has launched their latest online intervention program, which aims to change the course of patients with diagnosed pre-diabetes. The program, which features a highly individualized website, Android and iPhone apps, tailored emails, an interactive voice response coaching program, and tailored mailed newsletters, is the first of its kind to...

2014-02-21 12:24:13

OAKLAND, Calif., Feb. 21, 2014 /PRNewswire/ -- Women with low levels of an important protein known to bind to sex hormones prior to pregnancy were five times more likely to develop gestational diabetes than women with higher levels of the protein, according to a Kaiser Permanente study published today in the journal Diabetes Care. http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO "This study is among the first to find that low circulating levels of sex hormone binding...

2014-02-21 08:25:23

Trial Seeks to Examine the Effects of INVOKANA® on the Progression of Diabetic Nephropathy RARITAN, N.J., Feb. 21, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced the initiation of CREDENCE (Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation), a global, multicenter study of INVOKANA(®) (canagliflozin). This Phase 3 study is a randomized, double-blind, placebo-controlled, parallel group trial designed to enroll...

2014-02-19 23:01:46

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly suffer from Type 2 diabetes due to their use of Lipitor. New York, New York (PRWEB) February 19, 2014 Dozens of federally-filed Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) that allege the statin drug caused patients to develop Type 2 diabetes have been consolidated in a multidistrict litigation and transferred to the U.S. District Court, District of South Carolina, for pretrial proceedings. According...

2014-02-18 23:27:40

DNS Made Easy, the creators of Constellix, sponsors the 9th Annual Dodging Diabetes charity dodge ball tournament. Reston, VA (PRWEB) February 18, 2014 It’s time to dip, dive, duck and dodge. For team Constellix, joining the 9th Annual Dodging Diabetes charity dodge ball tournament March 9 is about building team spirit and workplace camaraderie. However, the ultimate goal is to help support the Juvenile Diabetes Research Foundation and the Joslin Diabetes Center. The Dodging Diabetes...

2014-02-12 12:31:53

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - Current and Future Players PharmaPoint: Type 2 Diabetes - Current and Future Players Summary GlobalData has released its pharma report, "PharmaPoint: Type 2 Diabetes - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Type 2 Diabetes Market. The report...

2014-02-12 12:31:50

In an unprecedented, challenging environment for reimbursement and choice for people with diabetes, ACCU-CHEK remains highest ranked brand INDIANAPOLIS, Feb. 12, 2014 /PRNewswire/ -- J.D. Power has announced that Roche Diabetes Care's ACCU-CHEK products rank "Highest in Customer Satisfaction with Blood Glucose Meters" among adults living with diabetes in the U.S. for the second year in a row according to the 2013 Blood Glucose Meter Satisfaction Study(SM). In a study comprised of...

2014-02-12 08:30:06

More than half a million dollars donated to help children with diabetes attend camp since 2008 INDIANAPOLIS and ALEXANDRIA, Va., Feb. 12, 2014 /PRNewswire/ -- News Highlights: -- #Lilly #Diabetes supports @AmDiabetesAssn #camps by donating $91,000 to send 91 children with diabetes to camp in 2014 -- #Lilly #Diabetes donates $91,000 to the @AmDiabetesAssn 2014 #camp program -- #Lilly #Diabetes supports scholarship program for children with #T1 #diabetes;...


Latest diabetes mellitus Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »